Medical device firm would be first Minnesota IPO in nearly 18 months.
Health Care + Med Tech
Mayo Clinic ranked as the runner-up on the national list.
The health organization hopes its latest collaboration will lead to more website traffic and a higher level of brand awareness.
A look at the Rochester clinic’s Top 10 National Institutes of Health awards.
Florida-based TapImmune exercises option, readies Phase II trials for HER2/neu cancer immunotherapy platform.
The medical device company also has another $25 million in the pipeline pending “the company’s achievement of a certain milestone.”
Regenerative, individualized medicine researchers seem likely picks for new Rochester buildings.
The addition of this testing method will shape future studies and could help doctors predict a patient’s chance of suffering from chronic disease.
Possible strike looms amid health plan dispute.
Developer Ryan Companies seeing health care demand.
The company faces over 36,000 lawsuits surrounding issues with the devices.
It’s all about priorities – and the price of health care doesn’t seem to be one of them.
The medical marijuana company will soon have operations in half of the state’s designated cannabis patient centers.
Construction will begin next year on the facilities that Mayo said are only a fraction of its Destination Medical Center expansion plans.
The clinic was an early investor in the company.
The company has thus far eschewed venture capital.
But annual cost pushed past $25,000 mark for first time, driven largely by prescription drug expenses.
Minneapolis innovation center eyes healthy growth for emerging health care companies.